Selected research
Market Structure
Global Enteric Softgel Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enteric Softgel Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enteric Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enteric Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enteric Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enteric Softgel Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enteric Softgel Capsules include Aenova, Alpha, BASF, Catalent, Dart Neuroscience, InovoBiologic, NutraNorth, ProCaps and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enteric Softgel Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enteric Softgel Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enteric Softgel Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enteric Softgel Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Enteric Softgel Capsules Segment by Company
Aenova
Alpha
BASF
Catalent
Dart Neuroscience
InovoBiologic
NutraNorth
ProCaps
Lonza
Sirio Pharma
Enteric Softgel Capsules Segment by Type
Gelatin Type
Vegetable Type
Enteric Softgel Capsules Segment by Application
Pharmacy & Drug Store
Online Retail
Supermarket & Hypermarket
Enteric Softgel Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enteric Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric Softgel Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enteric Softgel Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enteric Softgel Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enteric Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enteric Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gelatin Type
- Vegetable Type
Applications
- Pharmacy & Drug Store
- Online Retail
- Supermarket & Hypermarket
Companies covered
- Aenova
- Alpha
- BASF
- Catalent
- Dart Neuroscience
- InovoBiologic
- NutraNorth
- ProCaps
- Lonza
- Sirio Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enteric Softgel Capsules Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enteric Softgel Capsules Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enteric Softgel Capsules Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enteric Softgel Capsules Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enteric Softgel Capsules Market Dynamics
- 2.1 Enteric Softgel Capsules Industry Trends
- 2.2 Enteric Softgel Capsules Industry Drivers
- 2.3 Enteric Softgel Capsules Industry Opportunities and Challenges
- 2.4 Enteric Softgel Capsules Industry Restraints
3 Enteric Softgel Capsules Market by Manufacturers
- 3.1 Global Enteric Softgel Capsules Revenue by Manufacturers (2021-2026)
- 3.2 Global Enteric Softgel Capsules Sales by Manufacturers (2021-2026)
- 3.3 Global Enteric Softgel Capsules Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enteric Softgel Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enteric Softgel Capsules Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enteric Softgel Capsules Manufacturers, Product Type & Application
- 3.7 Global Enteric Softgel Capsules Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enteric Softgel Capsules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enteric Softgel Capsules Players Market Share by Revenue in 2025
- 3.8.3 2025 Enteric Softgel Capsules Tier 1, Tier 2, and Tier 3
4 Enteric Softgel Capsules Market by Type
- 4.1 Enteric Softgel Capsules Type Introduction
- 4.1.1 Gelatin Type
- 4.1.2 Vegetable Type
- 4.2 Global Enteric Softgel Capsules Sales by Type
- 4.2.1 Global Enteric Softgel Capsules Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enteric Softgel Capsules Sales by Type (2021-2032)
- 4.2.3 Global Enteric Softgel Capsules Sales Market Share by Type (2021-2032)
- 4.3 Global Enteric Softgel Capsules Revenue by Type
- 4.3.1 Global Enteric Softgel Capsules Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enteric Softgel Capsules Revenue by Type (2021-2032)
- 4.3.3 Global Enteric Softgel Capsules Revenue Market Share by Type (2021-2032)
5 Enteric Softgel Capsules Market by Application
- 5.1 Enteric Softgel Capsules Application Introduction
- 5.1.1 Pharmacy & Drug Store
- 5.1.2 Online Retail
- 5.1.3 Supermarket & Hypermarket
- 5.2 Global Enteric Softgel Capsules Sales by Application
- 5.2.1 Global Enteric Softgel Capsules Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enteric Softgel Capsules Sales by Application (2021-2032)
- 5.2.3 Global Enteric Softgel Capsules Sales Market Share by Application (2021-2032)
- 5.3 Global Enteric Softgel Capsules Revenue by Application
- 5.3.1 Global Enteric Softgel Capsules Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enteric Softgel Capsules Revenue by Application (2021-2032)
- 5.3.3 Global Enteric Softgel Capsules Revenue Market Share by Application (2021-2032)
6 Global Enteric Softgel Capsules Sales by Region
- 6.1 Global Enteric Softgel Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enteric Softgel Capsules Sales by Region (2021-2032)
- 6.2.1 Global Enteric Softgel Capsules Sales by Region (2021-2026)
- 6.2.2 Global Enteric Softgel Capsules Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enteric Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enteric Softgel Capsules Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enteric Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enteric Softgel Capsules Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enteric Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enteric Softgel Capsules Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enteric Softgel Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enteric Softgel Capsules Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enteric Softgel Capsules Revenue by Region
- 7.1 Global Enteric Softgel Capsules Revenue by Region
- 7.1.1 Global Enteric Softgel Capsules Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enteric Softgel Capsules Revenue by Region (2021-2026)
- 7.1.3 Global Enteric Softgel Capsules Revenue by Region (2027-2032)
- 7.1.4 Global Enteric Softgel Capsules Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enteric Softgel Capsules Revenue (2021-2032)
- 7.2.2 North America Enteric Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enteric Softgel Capsules Revenue (2021-2032)
- 7.3.2 Europe Enteric Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enteric Softgel Capsules Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enteric Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enteric Softgel Capsules Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enteric Softgel Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Aenova
- 8.1.1 Aenova Company Information
- 8.1.2 Aenova Business Overview
- 8.1.3 Aenova Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Aenova Enteric Softgel Capsules Product Portfolio
- 8.1.5 Aenova Recent Developments
- 8.2 Alpha
- 8.2.1 Alpha Company Information
- 8.2.2 Alpha Business Overview
- 8.2.3 Alpha Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Alpha Enteric Softgel Capsules Product Portfolio
- 8.2.5 Alpha Recent Developments
- 8.3 BASF
- 8.3.1 BASF Company Information
- 8.3.2 BASF Business Overview
- 8.3.3 BASF Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BASF Enteric Softgel Capsules Product Portfolio
- 8.3.5 BASF Recent Developments
- 8.4 Catalent
- 8.4.1 Catalent Company Information
- 8.4.2 Catalent Business Overview
- 8.4.3 Catalent Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Catalent Enteric Softgel Capsules Product Portfolio
- 8.4.5 Catalent Recent Developments
- 8.5 Dart Neuroscience
- 8.5.1 Dart Neuroscience Company Information
- 8.5.2 Dart Neuroscience Business Overview
- 8.5.3 Dart Neuroscience Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Dart Neuroscience Enteric Softgel Capsules Product Portfolio
- 8.5.5 Dart Neuroscience Recent Developments
- 8.6 InovoBiologic
- 8.6.1 InovoBiologic Company Information
- 8.6.2 InovoBiologic Business Overview
- 8.6.3 InovoBiologic Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 InovoBiologic Enteric Softgel Capsules Product Portfolio
- 8.6.5 InovoBiologic Recent Developments
- 8.7 NutraNorth
- 8.7.1 NutraNorth Company Information
- 8.7.2 NutraNorth Business Overview
- 8.7.3 NutraNorth Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 NutraNorth Enteric Softgel Capsules Product Portfolio
- 8.7.5 NutraNorth Recent Developments
- 8.8 ProCaps
- 8.8.1 ProCaps Company Information
- 8.8.2 ProCaps Business Overview
- 8.8.3 ProCaps Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ProCaps Enteric Softgel Capsules Product Portfolio
- 8.8.5 ProCaps Recent Developments
- 8.9 Lonza
- 8.9.1 Lonza Company Information
- 8.9.2 Lonza Business Overview
- 8.9.3 Lonza Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lonza Enteric Softgel Capsules Product Portfolio
- 8.9.5 Lonza Recent Developments
- 8.10 Sirio Pharma
- 8.10.1 Sirio Pharma Company Information
- 8.10.2 Sirio Pharma Business Overview
- 8.10.3 Sirio Pharma Enteric Softgel Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sirio Pharma Enteric Softgel Capsules Product Portfolio
- 8.10.5 Sirio Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enteric Softgel Capsules Value Chain Analysis
- 9.1.1 Enteric Softgel Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enteric Softgel Capsules Production Mode & Process
- 9.2 Enteric Softgel Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enteric Softgel Capsules Distributors
- 9.2.3 Enteric Softgel Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst